NEURON BIO, S.A.

Highlights Neuron Bio, S.A.

Equities

NEU

ES0166198012

End-of-day quote BME Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-.--%

2017	Neuron BioLabs, S.L. cancelled the acquisition of diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA.	CI
2017	Neol Biosolutions Seeks Investors	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Neuron BioLabs, S.L. cancelled the acquisition of diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA.	11/17/11	CI
Neuron Bio, SA completed the acquisition of 26.28% stake in NEOL Biosolutions, S.A..	23/17/23	CI
Neuron Bio, SA made an offer to acquire remaining 30.22% stake in NEOL Biosolutions, S.A. for €3.4 million.	14/16/14	CI
Neuron BioLabs, S.L. agreed to acquire diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA for €9 million.	14/16/14	CI
NEOL Biosolutions, S.A. has completed an IPO in the amount of €1.55 million.	28/15/28	CI
NEOL Biosolutions, S.A. has filed an IPO in the amount of €1.55 million.	10/15/10	CI
Neuron Bio, SA acquired 50% stake in NEOL Biosolutions, S.A. from Repsol, S.A. for €4.5 million.	17/14/17	CI
Repsol New Energy Ventures, S.A. acquired 50% stake in NEOL Biosolutions from Neuron BPh.	07/12/07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer